Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Carticel Autologous Cultured Chondrocyte Implantation

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 2 (1)
Phase 4 (1)

Trial Status

Completed3
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT06451120Phase 2Active Not Recruiting

Platelet Rich Plasma Injections In Young And Old Human Subjects

NCT06535204Not ApplicableCompleted

Effects of Anthriscus Sylvestris Leaves on Mild Knee Osteoarthritis

NCT00140634CompletedPrimary

The Objectives of the Cartilage Repair Registry is to Report Long Term Efficacy and Safety of Cartilage Repair Procedures in Registry Patients

NCT00158613Phase 4CompletedPrimary

Study of the Treatment of Articular Repair (STAR)

Showing all 4 trials

Research Network

Common Treatments

  • Carticel Autologous Cultured Chondrocyte Implantation2
  • Microcrystalline Cellulose1
  • Plateletrich Plasma Prp Injections1
  • Centrifuge1
  • Control Saline Injection1

Active Sponsors

  • Vericel Corporation2
  • Pusan National University Hospital1
  • University of California, San Francisco1

Top Investigators

Related Conditions

  • Osteoarthritis2
  • Cartilage Diseases1
  • Functional Food1
  • Musculoskeletal Disorders1

Activity Timeline